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Abstract
Aims: To assess the relationship between maternal clinical
chorioamnionitis and neonatal outcome in preterm very-low
birthweight (VLBW) infants.
Methods: An observational case-control study was conduct-
ed in the Neonatology Services of 12 acute-care teaching
hospitals in Spain. Between January 2004 and December
2006, all consecutive VLBW (F1500 g) infants born to a
mother with clinical chorioamnionitis were enrolled. Con-
trols were infants without chorioamnionitis matched by ges-
tational age who were born immediately after each index
case.
Results: There were 165 cases and 163 controls. A signifi-
cantly higher percentage of cases than controls required intu-
bation (53% vs. 35.8%), had normal intrauterine growth
(98.1% vs. 84.7%), were born in a tertiary center (inborn)
(95.1% vs. 89.1%), from single gestations (76.4% vs. 65.6%)
and vaginal delivery (47.3% vs. 33.3%), showed a lower
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Apgar score at 5 min, and presented a higher rate of early-
onset sepsis (10.4% vs. 1.2%). Older maternal age (32.5 vs.
30.8 years), premature labor (67.3% vs. 25.8%), premature
rupture of membranes (61.3% vs. 25.8%), and antibiotic
treatment (88.5% vs. 52.3%) were significantly more fre-
quent among cases than controls.
Conclusions: After controlling by gestational age, maternal
chorioamnionitis was associated with neonatal depression
and early sepsis but not with other prematurity-related
complications.
Keywords: Chorioamnionitis; fetal membranes; infant, pre-
mature; premature birth; premature rupture.
Introduction
Chorioamnionitis is considered to be one of the main causes
of preterm delivery and has been associated with adverse
perinatal outcomes in preterm infants. Preterm delivery
remains a major obstetric problem, accounting for 70% of
perinatal mortality and nearly 50% of long-term neurologic
morbidity w5x. In recent years, a great deal of attention has
turned to the impact of antenatal inflammation on both short-
term outcome and long-term sequelae in preterm infants. In
addition to severe acute morbidity, including early-onset sep-
sis, necrotizing enterocolitis and lung disease w2, 14x, the
preterm infant is at considerable increased risk of developing
intraventricular hemorrhage and periventricular leukomala-
cia, which, in turn, is a strong predictor of mental retardation
and cerebral palsy w8, 22, 23x. Histological chorioamnionitis
is associated with a decreased incidence of respiratory dis-
tress syndrome, whereas the incidence of bronchopulmonary
dysplasia is increased w1x. On the other hand, full-term babies
exposed to intrauterine infection often present with depressed
Apgar scores and neonatal encephalopathy, and are at marked
increased risk of developing cerebral palsy.
On the basis of the close association between infection
and very preterm birth, some authors have proposed that cho-
rioamnionitis plays a causal role not only in the induction of
delivery, but also in producing the fetal inflammatory
response syndrome, which is also considered as the cause of
acute morbidity as well as long-term sequelae in the infant
w8, 18x. Different studies have examined the effects of clin-
ical maternal chorioamnionitis and histological chorioamnio-
nitis on neonatal and neurodevelopmental outcome in
preterm babies w13, 19–21x. However, the interpretation of
these studies is complicated by the fact that important con-
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in the analysis. Therefore, a case-control study in which
cases and controls were matched by gestational age was
designed to assess the relationship between maternal clinical
chorioamnionitis and neonatal outcome in very-low birth-
weight (VLBW) preterm infants.
Methods
Between January 2004 and December 2006, the Neonatology Serv-
ices of 12 acute-care university-affiliated hospitals throughout Spain
participated in an observational, prospective, case-control study.
Cases were all consecutive preterm infants weighing F1500 g who
were born to a mother with history of clinical chorioamnionitis.
Controls were infants without such history matched by gestational
age, who were born subsequently to each index case. The diagnosis
of clinical chorioamnionitis in the pregnant woman who presented
with premature labor or premature rupture of the membranes was
made in the presence of uterine pain, fever (G388C), leukocytosis
()12,000 cells/mm3), and increased serum concentrations of C-
reactive protein ()30 mg/L). Common clinical manifestations, such
as malodorous vaginal discharge and maternal or fetal tachycardia
were not included as diagnostic criteria of clinical chorioamnionitis
in the study protocol. Infants with chromosomal or congenital
abnormalities were excluded from the study. The study was
approved by the Institutional Review Board of each participating
center, and written informed consent from the parents for data col-
lection was obtained. The inclusion of cases and controls in the
study did not involve any intervention. Infants received individu-
alized standard care according to current clinical guidelines.
A study protocol was designed in which the following data were
prospectively recorded: maternal age; premature labor (persistent
uterine contraction, morphological changes in the cervix); premature
rupture of membranes (clinical or biochemical evidence of amnior-
rhexis); intrapartum antibiotic treatment; antenatal steroid therapy
(one or more course of betamethasone); cesarean delivery; multiple
gestation; and whether the birth occurred in or outside the tertiary
care center (inborn, outborn). Preterm labor was usually defined as
regular contractions accompanied by cervical changes at
-37 weeks’ gestation w4x. Morphological changes in the cervix
included 2 cm dilatation or short cervical length (-25 mm) w9x.
Premature rupture of membranes was defined as spontaneous rup-
ture of membranes at -37 weeks’ gestation at least 1 h before the
onset of contractions. Diagnosis can be made clinically by evidence
of amniotic fluid in the vagina (pH testing, fluorescein injection) or
biochemically (fetal fibronectin testing) w3x. Newborn data included
gestational age, sex, weight at birth, intrauterine growth restriction
(IUGR) (below the 10th percentile using race- and sex-specific
growth charts); need of resuscitation maneuvers in the delivery
room using endotracheal intubation, and Apgar score at 5 min. Neo-
natal morbidity and mortality data included the presence of respi-
ratory distress syndrome, patent ductus arteriosus (and surgical
correction), necrotizing enterocolitis (and surgical treatment), sei-
zures, early-onset sepsis, late-onset sepsis, fungal sepsis, intraven-
tricular hemorrhage (and severe intraventricular hemorrhage grades
III and IV), periventricular leukomalacia, bronchopulmonary dys-
plasia or oxygen requirement at 28 days, chronic lung disease or
oxygen requirement at a corrected age of 36 weeks gestation, reti-
nopathy of prematurity (grade G2) (and laser treatment), death, and
survival without chronic lung disease. The length of hospital stay
was also recorded.
The Kolmogorov-Smirnov test was used to evaluate the distri-
bution of data. Normally distributed data are expressed as mean and
standard deviation (SD) and otherwise as median and interquartile
(25th–75th percentile) range. Categorical variables are expressed as
absolute numbers and percentages. Differences between cases and
controls were assessed with the Mann-Whitney U-test or one-way
analysis of variance (ANOVA) for continuous variables, and the chi-
square (x2) test for categorical variables. Odds ratio and 95% con-
fidence intervals (CI) were calculated to assess the magnitude of
the differences. The SPSS statistical package was used (version
12.0, SPSS Inc., Chicago, IL). P-value of -0.05 was considered
statistically significant.
Results
A total of 328 preterm babies weighing F1500 g were
recruited during the study period, and grouped into 165 cases
and 163 controls. Perinatal characteristics are shown in Table
1. Cases and controls were similar regarding weight at birth,
gestational age, and sex. IUGR occurred less frequently in
the group of infants with maternal chorioamnionitis than in
controls. In this group there were also more inborns, single-
tons, and vaginal deliveries. Moreover, resuscitation with
endotracheal intubation was needed more frequently and had
a lower 5-min Apgar score. Premature labor, premature rup-
ture of membranes, and antimicrobial therapy were also more
frequent among cases than controls.
As shown in Table 2, morbidity and mortality was similar
in both study groups. The only variable with significant dif-
ferences was early-onset sepsis, which occurred in 10.4% of
infants with maternal chorioamnionitis and in 1.2% in con-
trols (Ps0.001) (odds ratio 9.3, 95% CI 2.11–9.31). The
mortality rate was 23% in cases and 17.2% in controls. The
median length of hospital stay was 56 days in both cases and
controls.
Discussion
In the present prospective case-control study of VLWB pre-
term infants, those born from mothers with clinical cho-
rioamnionitis were more depressed at birth, required more
often neonatal resuscitation and endotracheal intubation, and
suffered from early-onset sepsis more frequently than con-
trols. These findings are consistent with a previous case-
control study carried out by our group on 135 newborns
weighing -1500 g at birth and born between 1988 and 1998
w7x. In this study, the cases comprised of 45 newborns
exposed to clinical or subclinical levels of maternal cho-
rioamnionitis. Each newborn in the case group was matched
with two controls, both weighing-1500 g, one of them born
immediately before and the other immediately after. Perinatal
records, neonatal morbidity and mortality were analyzed.
Forty percent of the cases presented sepsis in the first 72 h
of life compared with 10% of the controls (P-0.0001). In
addition, resuscitation (77.8% vs. 45.6%, Ps0.001) and
mechanical ventilation (73% vs. 50%, Ps0.016) were
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Table 1 Perinatal characteristics of the study population.
Variables Cases Controls P-value Odds ratio
ns165 ns163 (95% CI)
Maternal and labor data
Maternal age, years, mean (SD) 32.5 (5.3) 30.8 (5.5) 0.006
Premature labor 111 (67.3) 92 (56.4) 0.043 1.59 (1.01–2.48)
Premature rupture of membranes 98 (59.4) 41 (25.1) -0.001 4.55 (2.82–7.33)
Antibiotic treatment 112 (67.9) 46 (28.2) -0.001 20.45 (7.61–54.9)
Antenatal steroids 146 (88.5) 130 (79.7) 0.433
Cesarean delivery 87 (52.7) 108 (66.2) 0.010 0.56 (0.36–0.88)
Multiple gestation 39 (23.6) 56 (34.4) 0.032 0.59 (0.36–0.96)
Inborn 156 (94.5) 145 (88.9) 0.039 2.42 (1.02–5.75)
Newborn data
Males 86 (52.1) 91 (55.8) 0.501
Gestational age, weeks, median (IQR) 28.0 (26.4–29.7) 28.7 (27–29.8) 0.107
Birthweight, g, mean (SD) 1073 (246) 1040 (229) 0.216
IUGR 13 (7.9) 25 (15.3) 0.035 0.47 (0.23–0.96)
Apgar score at 5 min, median (IQR) 8 (7–9) 9 (8–9) -0.001
Endotracheal intubation 87 (52.7) 58 (35.6) 0.002 2.03 (1.30–3.16)
Data as number and percentages unless otherwise stated.
CIsconfidence interval, SDsstandard deviation, IUGRsintrauterine growth restriction, IQRsinterquartile range (25th–75th percentile).
Table 2 Morbidity and mortality during the neonatal period.
Variables Cases Controls P-value
ns165 ns163
Respiratory distress syndrome 101 (61.2) 109 (66.9) 0.391
Patent ductus arteriosus 52 (31.5) 60 (36.8) 0.370
Surgical correction 13/52 (25) 8/60 (13.3) 0.114
Necrotizing enterocolitis 15 (9.1) 14 (8.6) 0.888
Surgical treatment 8/15 (53.3) 9/14 (64.3) 0.549
Seizures 7 (4.2) 5 (3.1) 0.554
Early-onset sepsis 17 (10.3) 2 (1.2) 0.001
Late-onset sepsis 59 (35.7) 52 (31.9) 0.458
Fungal sepsis 17 (10.3) 8 (4.9) 0.066
Intraventricular hemorrhage 44 (26.7) 45 (27.6) 0.928
IVH grade III–IV 17 (10.3) 21 (12.9) 0.502
Periventricular leukomalacia 26 (15.7) 21 (12.9) 0.373
Bronchopulmonary dysplasia 49 (29.7) 49 (30.1) 0.716
Chronic lung disease 18 (10.9) 27 (16.6) 0.232
Retinopathy of prematurity (grade G2) 18 (10.9) 14 (8.6) 0.311
Laser treatment 6/18 (33.3) 6/14 (42.8) 0.082
Death 38 (23.0) 28 (17.2) 0.186
Length of hospital stay, days, median (IQR) 56 (28–76) 56 (39.5–73) 0.538
Alive without chronic lung disease 106 (64.2) 106 (65.0) 0.874
Data as number and percentages unless otherwise stated.
IQRsinterquartile range (25th–75th percentile).
rioamnionitis was associated with a higher risk of early onset
infection and the need for neonatal resuscitation and mechan-
ical ventilation.
Chorioamnionitis has been also associated with premature
rupture of membranes. In a review of 430 singleton preg-
nancies with confirmed premature preterm rupture of mem-
branes at 24 weeks or beyond that resulted in delivery at
-37 weeks, composite neonatal major and minor morbidity
rates were compared between pregnancies complicated by
chorioamnionitis and those that were not w16x. Thirteen per-
cent of women with premature preterm rupture of mem-
branes developed chorioamnionitis. The composite neonatal
major morbidity rate was significantly higher in neonates
whose mothers developed chorioamnionitis (55%) vs. those
who did not (18%, P-0.0001), and the incidence of cho-
rioamnionitis increased significantly with decreasing gesta-
tional age. For this reason, in our study, cases and controls
were matched by gestational age.
In a retrospective study on 452 preterm newborns
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the role of histological chorioamnionitis on the overall
morbidity of preterm newborns, an association only between
histological chorioamnionitis and cystic periventricular leu-
komalacia was observed w17x. In our study, examination of
the placenta to confirm histological chorioamnionitis was not
performed. However, the strength of association between his-
tologic chorioamnionitis and preterm delivery has been
inconsistent w10x. In another retrospective study of 100 wom-
en with singleton pregnancies between 22 and 28 weeks of
gestation and with chorioamnionitis diagnosed on admission
by amniotic fluid neutrophil elastase level, higher levels of
this biochemical marker were associated with a shorter inter-
val from admission to delivery w12x. In a retrospective
comparison of adverse neonatal outcome of singleton preg-
nancies with documented premature rupture of membranes
and chorioamnionitis (cases) with those who did not (con-
trols), poor neonatal outcome was significantly associated
with chorioamnionitis (34% vs. 13%, Ps0.008), confirming
that chorioamnionitis complicating premature rupture of
membranes worsens neonatal outcome w15x.
In contrast with studies with a retrospective cohort design,
the present prospective case-control study suggests that after
controlling for gestational age, complications, especially
related to prematurity rather than to chorioamnionitis, did not
appear to be significant. An increase in the occurrence of
intraventricular hemorrhage, severe intraventricular hemor-
rhage, periventricular leukomalacia, bronchopulmonary dys-
plasia, and chronic lung disease in the chorioamnionitis
group was not observed. According to our findings, maternal
chorioamnionitis was a risk factor for neonatal depression
and early-onset sepsis.
Inflammation has been implicated in the mechanisms
responsible for preterm and term parturition, as well as fetal
injury. Most cases of histopathological inflammation and his-
tological chorioamnionitis, both in preterm and term labors,
are subclinical in nature, and the isolation of bacteria in the
amniotic fluid is a pathological finding, the frequency of
which is dependent upon the clinical presentation and ges-
tational age w18x. The natural history of inflammation after
premature rupture of membranes can be modified by anti-
biotic administration, although antibiotic administration rare-
ly eradicates intra-amniotic infection in patients with preterm
premature rupture of membranes; moreover, some patients
with documented inflammation of the amniotic cavity show
a decrease in the intensity of the inflammatory process after
antibiotic administration w6x. Antenatal inflammation is very
commonly associated with preterm deliveries, but there is
generally minimal information about the duration, intensity,
or organisms associated with chorioamnionitis. In preterm
animal models, chorioamnionitis causes a lung injury similar
to bronchopulmonary dysplasia and also causes clinical lung
maturation. Continuous exposure of the developing lung
before and after delivery to inflammation may be central to
the development of bronchopulmonary dysplasia w11x. It
might be plausible that antimicrobials and antenatal steroids
in pregnant women with chorioamnionitis may decrease the
inflammatory response. In the present series, 88.5% of wom-
en received antenatal steroids, which may account for the
favorable outcome of neonates in the chorioamnionitis
group. However, the infectious/inflammatory mechanisms
involved in acute neonatal morbidity and mortality in pre-
term infants exposed to chorioamnionitis are incompletely
understood.
Although in this prospective clinical study the diagnosis
of histological chorioamnionitis was not made, we conclude
that after controlling by gestational age, maternal clinical
chorioamnionitis was associated with neonatal depression
and early-onset sepsis but not with other prematurity-related
complications.
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